PIPELINE
Staidson’s several molecules are in various stages of discovery and preclinical development.
Program | Indications | Discovery | Preclinical/IND-Enabling | Phase I (2021) | Phase II | Phase III |
---|---|---|---|---|---|---|
STSA-1005 | COVID-19/Autoimmune | |||||
SB-1901 | Immuno-Oncology | |||||
SB-1802 | Autoimmune Diseases | |||||
SB-1902 | Immuno-Oncology | |||||
SB-2001 | Immuno-Oncology | |||||
SB-2002 | Immuno-Oncology |